The Liver Meeting 2025 - All Programs

Create Account

Availability

On-Demand

7 Courses

Cost

Member: $150.00

Non-Member: $250.00

Patient: $0.00

Associate: $0.00

Student: $0.00

Early Career: $0.00

Industry Rep: $250.00

Credit Offered

52.5 AMA PRA Category 1 Credits

52.5 ABIM MOC Points

Description
Learning Objectives
Accreditation Information
Faculty and Disclosures

The Liver Meeting (TLM) serves as the premier educational opportunity in the specialty of hepatology, and as such includes programming that covers the breadth of the specialty. The meeting’s goal is to support the hepatology community in its efforts to improve care for patients with liver disease by highlighting the latest discoveries in basic, translational, and clinical science. This outcome is achieved through a combination of didactic podium presentations, interactive learning experiences, and poster and abstract presentations. Invited programs are developed by AASLD members, including the leaders in the many sub-specialty topics within hepatology, to cover late-breaking discoveries published in AASLD journals and guidelines; these sessions are designed to help attendees stay up to date on current best practices. Abstracts are submitted by researchers from around the world to present new scientific discoveries that will advance the field. Most attendees at The Liver Meeting 2024 reported that they would implement changes in their practices based on the lessons they learned at TLM, reinforcing the success of this programming process and its ability to generate education that addresses attendees’ learning needs.

Upon completion of this activity, participants should be able to:

- Discuss the latest basic, translational, and clinical research in hepatology with researchers and their peers
- Apply current guidelines and research to their practices, whether clinical care, education, or teaching
- Engage in peer to peer learning to reinforce lessons learned from meeting faculty

Accreditation Statement:

The American Association for the Study of Liver Diseases is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement:

The American Association for the Study of Liver Diseases designates this enduring material activity for a maximum of 53 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM Maintenance of Certification:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 53 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

NOTE: The post-test and evaluation are part of the overall evaluation process in order to receive credit. Please complete the evaluation and then return to the post-test to review the commentary and reference on all post-tests.

This online educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards for the Integrity and Independence for Accredited Continuing Education by members of the AASLD Transplant Hepatology Board Review Course faculty, the AASLD Maintenance of Certification Committee and the AASLD Governing Board. As an accredited provider, AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education.

The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity have been mitigated.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Faculty List

SPC Committee

CME Committee